Release Date: 02/09/16 16:39 Summary: Ceasing to be a substantial holder-KBL.AX Price Sensitive: No Download Document 101.56KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%